{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:46:28Z","timestamp":1792791988495,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsurgicalresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Surgical Research"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.jss.2022.01.001","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T21:01:27Z","timestamp":1643835687000},"page":"68-76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei"],"prefix":"10.1016","volume":"274","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4986-8738","authenticated-orcid":false,"given":"Andre","family":"Lopes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evandro Sobroza","family":"de Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7993-767X","authenticated-orcid":false,"given":"Rossana Veronica","family":"Mendoza Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Cesar","family":"Leonardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Ulysses","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jss.2022.01.001_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","article-title":"New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?","volume":"7","author":"Sugarbaker","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jss.2022.01.001_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/PPO.0b013e3181a9c781","article-title":"Epithelial appendiceal neoplasms","volume":"15","author":"Sugarbaker","year":"2009","journal-title":"Cancer J"},{"key":"10.1016\/j.jss.2022.01.001_bib3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/DCR.0000000000000719","article-title":"Histological subtype remains a significant prognostic factor for survival outcomes in patients with appendiceal mucinous neoplasm with peritoneal dissemination","volume":"60","author":"Huang","year":"2017","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jss.2022.01.001_bib4","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.jss.2022.01.001_bib5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ejso.2020.02.012","article-title":"Appendiceal tumours and pseudomyxoma peritonei: literature review with PSOGI\/EURACAN clinical practice guidelines for diagnosis and treatment","volume":"47","author":"Govaerts","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2022.01.001_bib6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1097\/DCR.0000000000001530","article-title":"The American Society of Colon and Rectal Surgeons, clinical practice guidelines for the management of appendiceal neoplasms","volume":"62","author":"Glasgow","year":"2019","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.jss.2022.01.001_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1097\/PAS.0000000000000535","article-title":"A consensus for classification and pathologic reporting of pseudomyxoma peritonei and associated appendiceal Neoplasia: the results of the peritoneal surface Oncology group International (PSOGI) modified Delphi process","volume":"40","author":"Carr","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jss.2022.01.001_bib8","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejso.2013.12.021","article-title":"Pre-operative tumour marker status predicts recurrence and survival after complete cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal Pseudomyxoma Peritonei: analysis of 519 patients","volume":"40","author":"Taflampas","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2022.01.001_bib9","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1245\/s10434-007-9393-9","article-title":"Prognostic value of circulating tumor markers in patients with pseudomyxoma peritonei treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","volume":"14","author":"Baratti","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2022.01.001_bib10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/bjs5.50134","article-title":"Factors influencing long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms","volume":"3","author":"van Eden","year":"2019","journal-title":"BJS Open"},{"key":"10.1016\/j.jss.2022.01.001_bib11","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1463-1318.2005.00773.x","article-title":"Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence","volume":"7","author":"Alexander-Sefre","year":"2005","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.jss.2022.01.001_bib12","doi-asserted-by":"crossref","first-page":"2908","DOI":"10.1007\/s11605-021-04953-y","article-title":"The utility of preoperative tumor markers in peritoneal carcinomatosis from primary appendiceal adenocarcinoma: an analysis from the US HIPEC Collaborative","volume":"25","author":"Fackche","year":"2021","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jss.2022.01.001_bib13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1055\/s-2005-916280","article-title":"Surgical management of carcinomatosis from colorectal cancer","volume":"18","author":"Sugarbaker","year":"2005","journal-title":"Clin Colon Rectal Surg"},{"key":"10.1016\/j.jss.2022.01.001_bib14","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s10434-999-0727-7","article-title":"Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy","volume":"6","author":"Sugarbaker","year":"1999","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2022.01.001_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2022.01.001_bib16","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1245\/s10434-007-9691-2","article-title":"Pseudomyxoma peritonei: clinical pathological and biological prognostic factors in patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"15","author":"Baratti","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2022.01.001_bib17","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1038\/modpathol.2014.37","article-title":"Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade","volume":"27","author":"Davison","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jss.2022.01.001_bib18","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1245\/s10434-012-2241-6","article-title":"Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms","volume":"19","author":"Austin","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2022.01.001_bib19","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1245\/s10434-009-0341-8","article-title":"Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years of experience from a single institution","volume":"16","author":"Chua","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2022.01.001_bib20","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1245\/s10434-014-3869-1","article-title":"Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy","volume":"21","author":"Jimenez","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2022.01.001_bib21","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s11605-019-04239-4","article-title":"Outcomes following cytoreduction and HIPEC for pseudomyxoma peritonei: 10-year experience","volume":"24","author":"Narasimhan","year":"2020","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jss.2022.01.001_bib22","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.ejso.2018.06.029","article-title":"Current practice of Latin American centers in the treatment of peritoneal diseases with cytoreductive surgery with HIPEC","volume":"44","year":"2018","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jss.2022.01.001_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jss.2012.12.040","article-title":"Improved survival of patients with pseudomyxoma peritonei receiving intraperitoneal chemotherapy with cytoreductive surgery: a systematic review and meta-analysis","volume":"183","author":"McBride","year":"2013","journal-title":"J Surg Res"},{"key":"10.1016\/j.jss.2022.01.001_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/jso.20107","article-title":"Utility of CEA and CA 19-9 tumor markers in diagnosis and prognostic assessment of mucinous epithelial cancers of the appendix","volume":"87","author":"Carmignani","year":"2004","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.jss.2022.01.001_bib25","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2016.02.022","article-title":"Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei","volume":"54","author":"Nummela","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jss.2022.01.001_bib26","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/BF02574513","article-title":"Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy","volume":"9","author":"van Ruth","year":"2002","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jss.2022.01.001_bib27","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/SLA.0b013e3182602ad2","article-title":"Inflammatory markers in blood and serum tumor markers predict survival in patients with epithelial appendiceal neoplasms undergoing surgical cytoreduction and intraperitoneal chemotherapy","volume":"256","author":"Chua","year":"2012","journal-title":"Ann Surg"},{"key":"10.1016\/j.jss.2022.01.001_bib28","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.ejso.2017.09.009","article-title":"CA 19-9 to peritoneal carcinomatosis index (PCI) ratio is prognostic in patients with epithelial appendiceal mucinous neoplasms and peritoneal dissemination undergoing cytoreduction surgery and intraperitoneal chemotherapy: a retrospective cohort study","volume":"43","author":"Kozman","year":"2017","journal-title":"Eur J Surg Oncol"}],"container-title":["Journal of Surgical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480422000026?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022480422000026?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T14:56:27Z","timestamp":1758380187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022480422000026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":28,"alternative-id":["S0022480422000026"],"URL":"https:\/\/doi.org\/10.1016\/j.jss.2022.01.001","relation":{},"ISSN":["0022-4804"],"issn-type":[{"value":"0022-4804","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei","name":"articletitle","label":"Article Title"},{"value":"Journal of Surgical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jss.2022.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}